BioCentury
ARTICLE | Company News

AdAlta, Crossbeta Biosciences deal

December 9, 2013 8:00 AM UTC

Crossbeta and AdAlta partnered to use AdAlta's i-body technology with Crossbeta's stabilized beta-amyloid oligomers to develop oligomer-specific i-bodies for therapeutic and diagnostic applications i...